Virios Therapeutics Inc expected to post a loss of 4 cents a share - Earnings Preview

Dogwood Therapeutics

07/05/2024 18:27

* Virios Therapeutics Inc  VIRI.OQ   VIRI.O  is expected
to show
no change in quarterly revenue when it reports  results on May 9
for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Virios Therapeutics Inc
is for
a loss of 4 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Virios
Therapeutics Inc is $2.20​, above​ its last closing price
of $0.41. ​​​

This summary was machine generated May 7 at 17:27 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)